Judith Klimovsky

Judith Klimovsky is the current Chief Development Officer at Genmab. Judith has over 25 years of experience in the pharmaceutical industry, with a focus on oncology clinical development.

Judith began their career in 1994 as Director of Clinical Research for BMS in Argentina. In 2003, they became Medical Director for Oncology at BMS, and in 2007 they were promoted to Regional Medical Director for LA.

In 2009, Klimovsky joined Novartis as Executive Medical Director for Oncology Clinical Development. During their time at Novartis, they were responsible for leading global clinical development programs and played a pivotal role in the launch of several oncology products. In 2013, they were promoted to Senior Vice President of Oncology Clinical Development, and in 2015 they were again promoted to Senior Vice President and Head of Clinical Development.

Klimovsky has played a critical role in the development and launch of several groundbreaking oncology treatments. Judith is a highly respected leaders in the field, and their experience will be invaluable as Genmab continue to develop innovative new treatments for cancer patients.

Judith Klimovsky received their MD from the University of Buenos Aires.

Judith Klimovsky works with Tahamtan Ahmadi - Chief Medical Officer & Head of Experimental Medicines, Christopher Cozic - EVP & Chief People Officer, and Anthony Pagano - EVP & CFO. Their manager is Jan G. J. van de Winkel, President & CEO.